Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Payables: 2011-2025

Historic Payables for SRx Health Solutions (SRXH) over the last 15 years, with FY2025 value amounting to $2.1 million.

  • SRx Health Solutions' Payables fell 9507.08% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 9507.08%. This contributed to the annual value of $2.1 million for FY2025, which is N/A changed from last year.
  • SRx Health Solutions' Payables amounted to $2.1 million in FY2025.
  • In the past 5 years, SRx Health Solutions' Payables registered a high of $7.1 million during FY2023, and its lowest value of $2.1 million during FY2025.
  • Its 5-year average for Payables is $4.0 million, with a median of $3.1 million in 2024.
  • Its Payables has fluctuated over the past 5 years, first tumbled by 5846.94% in 2021, then surged by 14181.45% in 2023.
  • Over the past 5 years, SRx Health Solutions' Payables (Annual) stood at $4.6 million in 2021, then plummeted by 35.6% to $2.9 million in 2022, then surged by 141.81% to $7.1 million in 2023, then tumbled by 55.75% to $3.1 million in 2024, then crashed by 31.56% to $2.1 million in 2025.
  • Its Payables was $2.1 million in FY2025, compared to $3.1 million in FY2024 and $7.1 million in FY2023.